L. Gilbert

VcR‐CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study

Christopher G. Peterson, Sangbum Choi, Jens C. Eickhoff et al. · British Journal of Haematology · 2011 · 51 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

38MO Progression-free survival (PFS) in primary advanced or recurrent endometrial cancer (pA/rEC) in the overall and mismatch repair proficient (MMR/MSS) populations and in histological and molecular subgroups: Results from part 2 of the RUBY trial

Mansoor Raza Mirza, S. Ghamande, L.C. Hanker et al. · ESMO Open · 2024 · 20 citations · Full text

Medicine, Oncology, Pharmacology +16

VcR-CVAD Produces a High Complete Response Rate in Untreated Mantle Cell Lymphoma: A Phase II Study from the Wisconsin Oncology Network

Brad S. Kahl, Julie Chang, Jens C. Eickhoff et al. · Blood · 2008 · 19 citations

Medicine, Biomedical Sciences, Oncology +12

Dostarlimab and niraparib in primary advanced ovarian cancer

Anne‐Claire Hardy‐Bessard, E. Pujade-Lauraine, Richard G. Moore et al. · Annals of Oncology · 2025 · 16 citations · Full text

Medicine, Oncology, Pharmacology +10